BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 25312590)

  • 1. Vasculitides and the Complement System: a Comprehensive Review.
    Chimenti MS; Ballanti E; Triggianese P; Perricone R
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):333-46. PubMed ID: 25312590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-Medium Vessel Vasculitides: is the Complement System a Potential Forgotten Target?
    Ballanti E; Chimenti MS; Perricone R
    Isr Med Assoc J; 2015 Feb; 17(2):85-92. PubMed ID: 26223083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complement system in systemic autoimmune disease.
    Chen M; Daha MR; Kallenberg CG
    J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammation.
    Borges T; Gomes AR; Santos J; Silva S
    Acta Reumatol Port; 2021; 46(1):58-68. PubMed ID: 33820892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Small Vessel Vasculitides.
    Lopalco G; Rigante D; Venerito V; Emmi G; Anelli MG; Lapadula G; Iannone F; Cantarini L
    Curr Rheumatol Rep; 2016 Jun; 18(6):36. PubMed ID: 27118389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New pathogenetic aspects in primary systemic vasculitides].
    Lamprecht P
    Internist (Berl); 2009 Mar; 50(3):291-7. PubMed ID: 19212730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurologic presentations of systemic vasculitides.
    Minagar A; Fowler M; Harris MK; Jaffe SL
    Neurol Clin; 2010 Feb; 28(1):171-84. PubMed ID: 19932380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of primary systemic vasculitides (II): ANCA-negative vasculitides].
    Guilpain P; Servettaz A; Tamby MC; Chanseaud Y; Le Guern V; Guillevin L; Mouthon L
    Presse Med; 2005 Aug; 34(14):1023-33. PubMed ID: 16225258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and clinical manifestations of immune complex vasculitides.
    Sunderkötter C; Golle L; Pillebout E; Michl C
    Front Med (Lausanne); 2023; 10():1103065. PubMed ID: 36936215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement and autoimmunity.
    Ballanti E; Perricone C; Greco E; Ballanti M; Di Muzio G; Chimenti MS; Perricone R
    Immunol Res; 2013 Jul; 56(2-3):477-91. PubMed ID: 23615835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Causes and mechanisms of systemic vasculitides].
    Mouthon L
    Rev Prat; 2008 Mar; 58(5):487-91. PubMed ID: 18524104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous alterations in vasculitides : Part 2: Special aspects of diseases of large, medium and small vessels].
    Sunderkötter C; Michl C
    Internist (Berl); 2019 Aug; 60(8):805-813. PubMed ID: 31300830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides With Glomerular IgA Deposition.
    Ma Y; Chen L; Xu Y; Han Q; Yu B; Zhao J; Hua Z; Yang Y; Chen J; Han F
    Appl Immunohistochem Mol Morphol; 2020; 28(10):e87-e93. PubMed ID: 31789820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.
    Ramirez GA; Maugeri N; Sabbadini MG; Rovere-Querini P; Manfredi AA
    Clin Exp Immunol; 2014 Feb; 175(2):150-66. PubMed ID: 24128276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin involvement in cutaneous and systemic vasculitis.
    Marzano AV; Vezzoli P; Berti E
    Autoimmun Rev; 2013 Feb; 12(4):467-76. PubMed ID: 22959234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of high mobility group box 1 in ANCA-associated vasculitis.
    Wang C; de Souza AW; Westra J; Bijl M; Chen M; Zhao MH; Kallenberg CG
    Autoimmun Rev; 2015 Nov; 14(11):1057-65. PubMed ID: 26209906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement After Trauma: Suturing Innate and Adaptive Immunity.
    Chakraborty S; Karasu E; Huber-Lang M
    Front Immunol; 2018; 9():2050. PubMed ID: 30319602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progranulin antibodies in autoimmune diseases.
    Thurner L; Preuss KD; Fadle N; Regitz E; Klemm P; Zaks M; Kemele M; Hasenfus A; Csernok E; Gross WL; Pasquali JL; Martin T; Bohle RM; Pfreundschuh M
    J Autoimmun; 2013 May; 42():29-38. PubMed ID: 23149338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases.
    Guilpain P; Mouthon L
    Clin Rev Allergy Immunol; 2008 Oct; 35(1-2):59-65. PubMed ID: 18228162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylatoxins spark the flame in early autoimmunity.
    Schanzenbacher J; Köhl J; Karsten CM
    Front Immunol; 2022; 13():958392. PubMed ID: 35958588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.